[Patent foramen ovale. An update for primary care]

Semergen. 2021 Apr;47(3):189-196. doi: 10.1016/j.semerg.2020.12.003. Epub 2021 Jan 26.
[Article in Spanish]

Abstract

Patent foramen ovale (FOP) is the most prevalent cause of cryptogenic strokes in people under 60 years old. Although it is usually asymptomatic, it has a high risk of producing paradoxical embolism and, therefore, stroke with indeterminate outcomes. The study should be started based on clinical suspicion, and includes a multidisciplinary assessment and a determination of the type of treatment to be performed. The therapeutic possibilities range from conservative treatment (indefinite antithrombotic treatment), to its percutaneous closure (currently the most widely used). The first objective is to decrease the number of stroke recurrences. Conservative treatment should be reserved for those cases of low embolic risk. The risk assessment must be individualised, fundamentally based on the anatomical characteristics of the FOP and the patient clinic picture. The use of the RoPE risk scale (The Risk of Paradoxical Embolism) should be a tool to consider.

Keywords: Actualización; Atención; Care; Foramen; Oval; Ovale; Permeable; Primaria; Primary; Update.

MeSH terms

  • Embolism
  • Embolism, Paradoxical
  • Foramen Ovale, Patent*
  • Humans
  • Middle Aged
  • Primary Health Care*
  • Risk Factors
  • Stroke
  • Treatment Outcome